|
Author: trainitright
Delta 9 Enters Licensing Agreement with Nanosphere Health Sciences
/NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES/
WINNIPEG, July 31, 2018 /CNW/ - DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") is pleased to announce it has signed memorandum of understanding (the "MOU") with Nanosphere Health Sciences Inc. (CSE: NSHS) ("Nanosphere"). The MOU provides that Delta 9 and Nanosphere intend to negotiate and enter into a master agreement (the "Agreement") pursuant to which Nanosphere will grant a master license for Nanosphere's patented technology to Delta 9 for all of Canada. Delta 9 may also sub-license the technology to other licensed producers of cannabis under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").
Nanosphere is a nano-biotechnology company focused on providing next generation delivery of nutritional elements and medications. The company's patented NanoSphere Delivery System™ platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds, including cannabinoids.
The NanoSphere Delivery System™ provides more bioavailability in comparison to other methods of delivery by transporting essential ingredients directly to the bloodstream and cells. Nanosphere's cannabis brand, Evolve Formulas, currently has products on sale in over 200 dispensaries across Colorado and has signed licensing agreements to bring products to California and Arizona in the coming months. It also holds the patent for delivery of cannabis via phospholipid nanoparticles, as well as a master patent covering its core technology.
"We are very excited to reach this agreement with Nanosphere," said Delta 9 CEO John Arbuthnot. "We believe Nanosphere has developed on of the world's most advanced delivery system for cannabinoids. We believe this partnership will revolutionize the medical use of cannabis in Canada and around the world, and that it also has important applications in the recreational market."
Nanosphere has developed a delivery system that shrinks active drug ingredients and encapsulates them in phospholipid nanoparticles, allowing the agents, including cannabis, to pass through skin or mucous membrane and go straight into the bloodstream. This process allows for a significant increase in the bioavailability of the drug, and also allows for extremely precise dosage of any drug, including cannabis. Nanosphere products can be applied as a transdermal viscous gel that absorbs into the skin; as an intranasal product for fast-acting effects; or as an intraoral product which is absorbed through the mucous membrane into the bloodstream.
Robert Sutton, Chairman and CEO of Nanosphere, says the agreement marks a great stride forward for his company. "With this agreement we have a trusted and experienced partner in the only G7 nation that has legalized cannabis for both medical and recreational use," Sutton said. "This allows Nanosphere's technology to be subjected to clinical trials and to be appropriately distributed to both patients and to recreational users of cannabis. We hope through our work to eliminate the need for patients to be essentially "smoking their medicine", and to give physicians a new and important tool to treat conditions that respond to cannabinoids."
The MOU provides that Delta 9 and Nanosphere will each receive 50 per cent of the net revenue from sales of Nanosphere products in Canada if the Agreement is entered into. Delta 9 will have the right to sub-contract distribution to third-party license holders in Canada where the opportunity exists. Under those circumstances, Delta 9 would receive a portion of that sub-licensee's net profit, and remit 50 per cent of the net revenue to Nanosphere.
The initial term of the Agreement is intended to be 36 months following the date of the first commercial sale of licensed products pursuant to the Agreement. The Agreement is intended to be renewed by mutual agreement of the parties. Also, if the Agreement is entered into, Delta 9 is bound to apply to Health Canada for authorization to distribute Nanosphere products. The parties intend that the MOU will be replaced by the Agreement within 60 days, upon completion of due diligence by both parties.
About Delta 9 Cannabis Inc.
Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9's shares trade on the TSX Venture Exchange under the symbol "NINE".
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) the entering into of the Agreement, the terms of the Agreement and the granting of the license for Nanosphere's products to Delta 9; (ii) the development of Nanosphere's products; and (iii) sublicensing of Nanosphere's products by Delta 9. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that Delta 9's currently contemplated expansion and development plans may cease or otherwise change, Delta 9's production of cannabis may be lower than expected, Delta 9 may not obtain the required approvals from Health Canada, demand for Delta 9's products may be lower than anticipated, Delta 9's cost to produce its grow pods may be higher than expected and all other risk factors set forth in the annual information form of Delta 9 dated May 31, 2018 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.
SOURCE Delta 9 Cannabis Inc.
Hello. This is us! We're staying home for the day. We refuse to leave our bed. This is our space. Our shelter. Today, this is the whole universe!
And it's okay. We're surrounded by our favorite sacred things. Each one has something gentle to offer.
And we'll be okay. Let's practice some #SelfCare together. Let's start with a little breathing exercise...
Breathing slowly connects us to our bodies and gives us life. Mmmmmm. We can breathe for as long as we'd like. There's no hurry. There's no end. We breathe and we listen to ourselves.
In this universe, our goal is simply to feel better. There's no winning, no failure, no score. No difficulty, no ads, no notifications. There is just us and our feelings.
Join us here, in this room, for a few moments. This room is our escape. <3
TORONTO, CANADA (July 31, 2018) — Today the innovative developers of therapeutic technologies at TRU LUV released their latest digital companion #SelfCare, a game-like app that allows you to reset, recharge and reemerge anew.
In this world ruled by digital overload, TRU LUV takes your phone past being a tool for personal betterment and onto providing a truly restorative immersive experience — one that replaces mindless scrolling with mindful intention.
The setting for #SelfCare is as simple as the process: Let’s stay in bed all day. In your virtual bedroom, surrounded by your favorite gentle things, you select calming tasks that generate simple satisfaction and uncomplicated harmony. Awaken your slumbering cat and give it some deserved affection, sort your laundry by color, indulge in a tarot card reading, or nurture your favorite plant. It’s your safe, comfortable space where you give yourself permission to feel better.
Unlike traditional games that get increasingly more stressful as you progress, the #SelfCare interactions begin disorderly and awkward and become more orderly and satisfying. There are no levels of difficulty, no winning, and no losing. The goal is simple: To feel better.
“#SelfCare is an antidote to a stressful world and a phone full of bad news, FOMO, and more stress,” say co-creators Brie Code and Eve Thomas. “For 3-5 minutes you can escape to a calm and soothing room, do some relaxing, meditative tasks, and return to your life refreshed and ready to face your stresses.”
As your #SelfCare experience progresses you can personalize your virtual sanctuary with unique additions contributed by guest artists working in themes of self-care, updating your space to reflect the evolution of your goals and outlook. The more time you spend on yourself, the more self-care techniques are unlocked for a deeper and more impactful practice.
Download #SelfCare, now available for iPhone.
For more information visit TRU LUV. For all media inquiries contact Sarah Bronilla at VOCAL.
LAUNCH DATE: 31 JULY 2018, IOS
ABOUT TRU LUV
TRU LUV wants you to feel better. Our phones cause us anxiety. TRU LUV's beautiful interactive experiences leave you feeling calm, connected, and invigorated.
We work together with artists and neuropsychologists to bring life to heartening companions who help you achieve your goals. In TRU LUV's framework, you don't tell your phone what you need, and your phone doesn't tell you what you need. Instead, you work together towards shared goals. You help each other.
The company was founded by Brie Code, former AI lead on Assassin's Creed.
ABOUT BRIE CODE
Brie Code is a leader in the field of interaction design with a special interest in the future of interactive media and artificial intelligence. Previously she was an AI lead at Ubisoft Montreal on the soft, ethereal game Child of Light and three Assassin's Creed games.
ABOUT EVE THOMAS
Eve Thomas is a writer, magazine editor, and artist whose work has appeared in EnRoute, The Toast, and Canadian Art. She is also the creator of Degrassi! The Musical and co-creator of the Tiger Beat-inspired Poster Boys portrait series, which launched at Never Apart Gallery.
Women and Lupus – Tackling the Debilitating Connection
With $2 Million Grant, UH Researcher Unraveling the Link
HOUSTON, July 31 – The chronic inflammatory disease systemic lupus erythematosus (known as SLE or lupus), is about nine times more common in women than men, and a University of Houston researcher now has the money to find out why. The National Institutes of Health has awarded Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, $2 million dollars to examine the connection.
Mohan knows just where he’s taking the money – straight to the bank. Bank1, that is, a critical gene in B-Lymphocytes, immune cells which make the antibodies that cause lupus when they misguidedly attack the body’s own cells.
“Bank1 exists in men and women, but in women the consequences are more drastic because the Bank1 gene and female hormones work together on the same pathway and make even higher levels of disease-causing auto antibodies,” said Mohan.
Genetic studies have led to the identification of several genes involved with lupus, but how they operate is still unclear. One of these genes is the Bank1.
“We will examine how the Bank1 impacts B-cell function and disease, in concert with female sex hormones,” said Mohan. “A unique aspect of this grant is its focus on unraveling why females are more prone to lupus, by factoring in the contributions of culprit genes and estrogens.”
Merely having a target is a step forward in the investigation of the complex autoimmune disease that is difficult to diagnose and treat because it is a multisystem disorder typically impacting skin, joints and kidneys. The disease is characterized by high levels of anti-nuclear autoantibodies and B-cell hyperactivity. Only one treatment for lupus has been approved in nearly 60 years.
Mohan will examine the molecular mechanisms through which lupus genes and sex hormones interface to cause autoimmunity. A better understanding of the pathogenic mechanisms underlying the disease will also pave the way towards better therapeutics, he said.
Mohan is one of the leading lupus researchers in the world. For more than three decades he’s been exploring the disease on different fronts.
“There are three major areas we need advances on concerning lupus,” said Mohan. “We need a better understanding of the disease, we need to know if we can diagnose and monitor the disease better using better biomarkers, and we need to know superior ways to treat the disease.”
On this grant Mohan is joined by Chin-Yo Lin of the UH Center for Nuclear Receptors and Cell Signaling and biologist Anne Satterthwaite of UT Southwestern Medical Center in Dallas.
About the University of Houston
The University of Houston is a Carnegie-designated Tier One public research university recognized with a Phi Beta Kappa chapter for excellence in undergraduate education. UH serves the globally competitive Houston and Gulf Coast Region by providing world-class faculty, experiential learning and strategic industry partnerships. Located in the nation's fourth-largest city and one of the most ethnically and culturally diverse regions in the country, UH is a federally designated Hispanic- and Asian-American-Serving institution with enrollment of more than 45,000 students.
Ontario Nurses, Health-Care Professionals in Hospital Sector Receive Arbitration Award
TORONTO, July 31, 2018 /CNW/ - Ontario Nurses' Association (ONA) nurses and health-care professional members working in the hospital sector will learn details of their new two-year contract today.
The contract for 61,000 hospital members is the result of an arbitration award; the contract includes a wage increase of 1.4 per cent retroactive to April 1, 2018 and a 1.75-per-cent increase on April 1, 2019. The contract expires on March 31, 2020.
"These wage increases do not reflect the value of the care of our dedicated members," said ONA President Vicki McKenna, RN. "However, they are significantly higher than the increases proposed by the employer. This contract is certainly not everything our dedicated registered nurses and health-care professionals hoped it would be. However, the award does provide for some improvement in benefits, and it clarifies that the obligation to keep workplaces free from violence includes being free from domestic violence.
"Heavy workload issues and workplace violence continue to be of deep concern to ONA members," McKenna notes, "as they impact both the safety of their patients and their own work lives."
In addition, there is now protection for new nursing graduates who do not pass the controversial NCLEX entry-to-practice exam. "Rather than being terminated if they have secured employment, the nursing graduates can take an unpaid leave until they achieve certification," McKenna said.
McKenna notes that arbitrator William Kaplan did not agree to the concessions sought by the Ontario Hospital Association.
ONA is the union representing 65,000 registered nurses and health-care professionals, as well as 18,000 nursing student affiliates, providing care in hospitals, long-term care facilities, public health, the community, clinics and industry.
Visit us at: www.ona.org; Facebook.com/OntarioNurses; www.Twitter.com/OntarioNurses
SOURCE Ontario Nurses Association
Simple Steps To Stop Progression Of Dementia And Alzheimer's
Chattanooga, TN, July 30, 2018 ― Dr. Timothy R. Jennings speaks expertly on a subject that concerns over 5.5 million people across the nation: how to prevent dementia and keep our mind sharp as we age. A psychiatrist and international speaker, Jennings introduces his new book, recently rated #1 by Amazon in books on dementia, The Aging Brain: Proven Steps to Prevent Dementia and Sharpen Your Mind.
Dr. Jennings prescribes simple, everyday actions we can take to stave off disease, promote vitality, and prevent dementia and late-onset Alzheimer's. "The choices we make now can help us to keep our minds sharp and maintain our independence as we age,” says Jennings.
An easy-to-use guide to maintaining brain and body health throughout life, The Aging Brain is based on solid, up-to-date scientific research, and the interventions discussed may help prevent progression toward dementia, even in those already showing signs of mild cognitive impairment. The recommendations also may help reduce disability and depression.
"This book isn't just for people hoping to slow the aging process,” says Jennings. "It's also for anyone who is a caregiver to someone at risk of or already beginning to suffer from dementia. It offers a hopeful, healthy way forward.”
Jennings, who maintains a private practice in Chattanooga, TN, has authored several books, including The God-Shaped Brain and The God-Shaped Heart. He is a Distinguished Fellow of the American Psychiatric Association and Fellow of the Southern Psychiatric Association, and is president and founder of Come and Reason Ministries.
For more information about Dr. Jennings, please visit the website: https://www.agingbrainbook.com.
To connect with Dr. Jennings, please visit: https://www.facebook.com/DrTimJennings/ and https://twitter.com/timjenningsmd.
What to Do When You Knock out a Tooth during Your Workout
Dental emergencies are no laughing matter at all. If you manage to knock a poor tooth out in the middle of a fast-paced exercise session, it’s not the end of the world, though. It’s critical to keep your full composure in times of urgent tooth-related dilemmas. If you remain calm and take a deep breath, you can get through any tooth disaster on the planet.
Stop Your Workout Immediately
It doesn’t matter if you’re a perfectionist. You can’t finish your workout with a tooth that’s sadly no longer inside of your mouth. Terminate your workout without a second of hesitation. Knocked out teeth are pressing emergencies. You need to take care of them as soon as possible. The sooner you take action, the better you’ll feel.
Retrieve the Tooth Via the Crown
It’s critical to retrieve the knocked out tooth via its crown. Never do so via its root. Get your tooth without waiting. Don’t give it the chance to linger on the floor or anywhere else. Refrain from making any contact with the root. This is critical for people who want to keep lost teeth in tiptop shape.
Get in Contact with Your Dentist
Give your dentist’s office a phone call immediately. This only works during business hours, though. If you’re able to get in contact with a staff member, find out if they can squeeze you in for an emergency appointment. Tell the representative your situation. Tell them that you cannot wait around long for dental care. You shouldn’t wait for longer than half an hour or so. Implant dentistry servicescan be a great option for people who have missing teeth.
Look for Emergency Dentists in Your Area
If your tooth crisis took place after business hours, you don’t have to feel vulnerable or stressed out. That’s because there are dependable emergency dentists who can help you take care of your knockout situation. Request recommendations for emergency dental clinics from people you know. Search the Internet for credible and trusted emergency dental offices, too. If you find a clinic that seems like a good fit for you, try to make an appointment without a second of deliberation.
Don’t wait to manage a knocked out tooth crisis. Be composed and do something about it swiftly. Emergency dental care may be your finest bet. Find out about implant dentistry and any other options that may be on hand for you.
BP is entering the US unconventional to gain on other IOCs in the large-scale multiple plays game, says GlobalData
Following the news (Friday 27 July) that BP is to acquire BHP’s US onshore unconventional positions in Permian, Eagle Ford and Haynesville and the analysis of Q2 earnings from ExxonMobil and Chevron, Adrian Lara, Senior Oil & Gas Analyst at GlobalData, a leading data and analytics company, offers his view on how this will impact the upstream sector:
“BP has definitely paid a premium on the US$10.5bn deal, based on GlobalData’s analysis of existing production acreages and expectation for undeveloped positions. The undeveloped acreage has different net present values depending on whether it is Eagle Ford, Permian or Haynesville. The Permian acreage is of particular value given its stacked formations, thickness and the available infrastructure. The current pipeline bottlenecks are a short term issue which should not matter much in the longer term strategy of acquiring unconventional assets with large reserves and quick development timeline.
“As with any other major international oil company (IOC) in the US unconventional sphere, the expectation for BP is to use its main advantage over more traditional mid and small size operators, which is the amount of capital expenditure (capex) the company can pour into large drilling programs and the operating efficiencies it can gain due to scale.
“This is exactly what ExxonMobil and Chevron have accomplished for a continuous increase in production in their Permian positions. The two companies are currently operating 34 and 19 rigs respectively in the play, aiming for double digit growth.”
BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer
HERZLIYA, Israel, July 30, 2018 /CNW/ - BlueWind Medical, a developer of a miniature, wireless neurostimulation platform for the treatment of multiple clinical indications, announced today the appointment of Dr. Roger R. Dmochowski of Vanderbilt University as the company's chief medical officer (CMO). Dr. Dmochowski will be leading clinical efforts, including the upcoming OASIS(OverActive bladder StImulation System study) pivotal trial of RENOVA iStim™ for the management of overactive bladder (OAB). The study is expected to commence in early 2019, with an overall target of 250 patients to be implanted with RENOVA iStim™ in up to 25 medical centres in several European countries.
Dr. Dmochowski is a world-renowned leader in the fields of urology, OAB and incontinence, a recipient of the Zimskind Award and Lifetime Achievement Awards from the Urodynamics Society for his accomplishments in the clinical treatment for incontinence, a Fellow of the American College of Surgeons, a member of the American Urological Association and International Continence Society, and a trustee of the American Board of Urology. An accomplished scholar, Dr. Dmochowski has published over 320 articles, 100 book chapters and 460 abstracts, given over 260 presentations at various national and international meetings, led and participated in dozens of OAB and incontinence studies, is the Editor-in-Chief of NeuroUrology and Urodynamics, and serves on the editorial board for several scientific journals. Dr. Dmochowski will continue to serve in clinical and academic roles with the Vanderbilt university as well as other medical association positions.
"I am extremely pleased to be able to provide medical oversight to the clinical trial of the RENOVA iStim™, which I believe will have a significant positive impact on patients' lives," said Dr. Dmochowski.
"We are delighted to formally welcome Dr. Dmochowski to our team, and we are certain he will add great value to BlueWind through his knowledge, experience and enthusiasm," commented Guri Oron, BlueWind's CEO.
About BlueWind Medical
BlueWind Medical was founded in 2010 by Rainbow Medical. The company is developing a platform technology of miniature, wireless, neurostimulators that can be injected or implanted in a minimally invasive procedure to treat multiple indications. By putting patients' needs first, BlueWind Medical's team of experienced and dedicated engineers and researchers are creating a versatile and effective platform that will transform neuromodulation as we know it.
About Rainbow Medical
Rainbow Medical (http://www.rainbowmd.com ) is a unique private operational investment company that seeds and grows start-up companies developing breakthrough medical devices, addressing significant unmet market needs in a diverse range of medical fields.
SOURCE BlueWind Medical
We all know, good nutrition is crucial for health (and this is especially true as you get older) ...but did you know that eating healthy doesn't necessarily mean your body is getting the right nutrients?! Many women don't realize they have a condition called "enzyme gap" which means even if they eat healthy, their body won't benefit because there aren't enough enzymes to absorb the nutrients! Enzyme gap may not only cause digestive problems, but it can also weaken the immune system and lead to a slew of other health issues like fatigue, acne, eczema, headaches, mood swings, joint pain, etc.
Luckily, there is an organic and healthy way to ensure you are getting the most out of those fruits and veggies!
ABOUT EVERYDAY ENZYMES:
Everyday Enzymes are an organic, all-natural supplement designed to help your body digest and absorb the maximum amount of nutrients. It supports the digestion of carbohydrates, proteins, and fats. This supplement can help not only with digestive issues (acid reflux, nausea, gas, etc.) but it can also boost the immune system, metabolism, and improve overall health. Everyday Enzymes may be given to young children, pets and it may even be taken during pregnancy / lactation. (In fact, expectant mothers find it helps with nausea!)
Digestive Enzymes Will Help You:
- Eliminate abdominal pain, bloating, gas, and acid reflux.
- Get the most nutrition out of the food you are already eating.
- Get off of pharmaceutical or over-the-counter drugs.
WHY YOU NEEDS THIS:
We live in a quick-fix, medicine-hungry nation....but medicine is not always the answer! Our body can heal itself if given the chance and this drug-free, all-natural supplement will allow you to do that.
Many people suffer from minor (or major) stomach issues (like gas, bloating, acid reflux) and while taking Tums or Pepto Bismol may provide relief...it is merely helping the symptoms, not the problem. Everyday Enzymes get to the root of the problem and have been proven to be extremely effective in getting people off pharmaceutical or over-the-counter drugs for digestive issues.
A healthy stomach often benefits many other areas of health. Even if you don't have stomach problems, these supplements can help boost your immune system, fight fatigue, and even help with anxiety.
"Patients are shocked to learn that their stomach may be the cause of their other health problems," says the creator, Dr. Liz Cruz.
As a gastroenterologist and a parent of four kids, Cruz is determined to keep herself feeling good and staying healthy for her family in the most natural way possible. "It's amazing to see people get off pharmaceutical drugs in an all-natural way. This information and these tools need to be shared with everyone now more than ever! It's never too late to change how you feel," adds Cruz.
THE SCIENCE BEHIND DIGESTIVE ENZYMES:
In order for your body to benefit from what you eat, you need digestive enzymes to break down the food. Proteins need to be broken down into amino acids; fats need to be broken down into fatty acids and cholesterol; and carbohydrates need to be broken down into simple sugars. At birth we are given a certain potential for manufacturing enzymes in our body, creating an enzyme “reserve.” However, if we do not continually replenish that reserve through proper nutrition, it runs out. Enzyme deficiency can cause digestive issues, a weakened immune system, fatigue, acne, eczema, headaches, mood swings, joint pain.
Dr. Cruz is on a mission to educate women and help them adapt to a healthy lifestyle s they age.
ABOUT DR. LIZ CRUZ:
Dr. Liz Cruz is a gastroenterologist, an author, and (most importantly,) a parent of four children. She is the creator of Everyday Enzymes, as well as a variety of other wellness products designed to promote all-natural, holistic wellness. Cruz's products have received critical acclaim and are widely praised for effectively reducing the need for prescription medicine. Cruz is a Diplomat of the American Board of Internal Medicine and the American Board of Gastroenterology. She is a member of the American Gastroenterological Association and the American Society for Gastrointestinal Endoscopy.
For More Information Visit:
